Vicore Pharma Holding AB (VICO) NPV

Sell:8.16 SEKBuy:8.20 SEK0.22 SEK (2.76%)

Prices delayed by at least 15 minutes
Sell:8.16 SEK
Buy:8.20 SEK
Change:0.22 SEK (2.76%)
Deal now
Prices delayed by at least 15 minutes
Sell:8.16 SEK
Buy:8.20 SEK
Change:0.22 SEK (2.76%)
Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

Vicore Pharma Holding AB is a Sweden-based drug-development company. The Company's portfolio contains small molecules with potential indications, including anti-inflammation, nerve generation and cardiovascular disease. The Company is a wholly owned subsidiary of Mintage Scientific AB.

Key people

Hans Schikan
Independent Chairman of the Board
Ahmed Mousa
Chief Executive Officer
Hans Jeppsson
Chief Financial Officer
Nina Carlen
Chief Administrative Officer
Johan Raud
Chief Scientific Officer
Mikael Nygard
Vice President - Operations and Corporate Strategy
Elin Rosendahl
Vice President - Clinical Development
Jimmie Hofman
Vice President - Business Development
Sophie Bertilsson
Interim Head of CMC
Johanna Graens
Program Director - Early Development
Yasir Al Wakeel
Director
Ann Barbier
Director
Elisabeth Bjork
Independent Director
Michael Buschle
Independent Director
Heidi Hunter
Independent Director
Click to see more

Key facts

  • EPIC
    -
  • Location
    Sweden
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    SE0007577895
  • Market cap
    SEK 1.87bn
  • Employees
    29
  • Shares in issue
    111.73m
  • Exchange
    Stockholm Stock Exchange
  • Index
    SX All Share PI Market Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.